We report a boy with relapse of diabetes after 82 months (6.8 years). This boy was hospitalized with severe DϩHUS when he was 6 years old. During his stay in the intensive care unit, he developed hyperglycemia and was treated with insulin during 21 days. Eighty months later he presented with nose obstruction and headache and was diagnosed with sinusitis and polyposis nasi. He was treated with antibiotics, but the complaints persisted. Two months later, he was operated on (functional endoscopic sinus surgery), and postoperatively he received 2 mg betamethason for 5 days. On the 5th day, he presented in the emergency department with polyuria, polydipsia, and lethargy. His glycemia was 1,500 mg/dl, and his blood pH was 7.33. He was intravenously treated with insulin, and the corticosteroids were ceased.
Maternal Age and Prevalence of Gestational Diabetes Mellitus

M
aternal age is an established risk factor for gestational diabetes mellitus (GDM), but there is no consensus on the age above which there is significantly increased risk of GDM. In the literature, the lowest cutoff is Ն25 years, as recommended by the American Diabetes Association (1) , but there are little data to support this recommendation. To determine the age threshold for increased risk of GDM, we have reviewed the prevalence of GDM, diagnosed by the World Health Organization criteria (2) , in the singleton pregnancies managed in our department from 1998 to 2001. Data on maternal anthropometric parameters, parity status, and risk factors for GDM such as booking weight Ն70 kg, BMI Ն25 kg/m 2 , chronic hypertension, significant medical history, and smoking, as well as risk factors identified in our population that included carrier of thalassemia trait (3) and HBsAg (4) and presence of iron deficiency anemia, which reduces the risk of GDM (5), were retrieved from a computerized database. The pregnancies were categorized according to maternal age, i.e., Յ20 years, 20 -24 years, 25-29 years, 30 -34 years, 35-39 years, and Ն40 years, for statistical analysis (SPSS for Windows version 11.0; SPSS, Chicago, IL) using the 2 test and Pearson's correlation. Multivariate analysis was used to determine the role of advancing maternal age adjusting for the other significant associated factors, and the adjusted relative risk and 95% CI was calculated for each age cohort with the 20 -24 years cohort as the reference.
Of the 16,383 women managed in this period, 15,827 (96.6%) women continued their pregnancies beyond the first trimester, and the number (% of total) from the youngest to the oldest cohort were 318 (2.0%), 1,713 (10.8%), 4,446 (28.1%), 5,457 (34.5%), 3,279 (20.7%), and 614 (3.9%), respectively. There was a significant difference and positive correlation in the prevalence of GDM, increasing from 1.3, 2.5, 6.2, 10.3, 21.7, and 31.9%, respectively, from the youngest to the oldest cohort (P Ͻ 0.001). On multivariate analysis and adjusting for significant confounding factors that included weight Ն70 kg, BMI Ն25 kg/m 2 , HBsAg ). There was no significant difference for the Ͻ20 years cohort. Our finding indicates that the risk of GDM becomes significantly and progressively increased from 25 years onwards. This supports the American Diabetes Association recommendation on the use of age Ն25 years as the cutoff for screening and the observation that maternal age Ն25 years is the factor most predictive of GDM (6). In clinical practice, maternal age of Ն25 years should be adopted instead of Ն35 years or 40 years as a risk factor for the development of GDM. 
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S
ince hyperinsulinemia tracks from childhood to adulthood and is associated with diabetes risk, identifying modifiable conditions during gestation that may impact insulin metabolism in offspring is important. We conducted a pilot study to investigate associations between maternal weight gain and infant insulin concentrations in an underserved population at high risk for diabetes. Mexican or Native American women with an infant Ͻ1 year of age provided written consent. Infant weight-for-age Z scores (WAZ) were calculated, and nonfasting plasma samples were analyzed for insulin by standard assay. Pearson's bivariate test was used to assess relationships between variables, and the unpaired t test was used to examine differences between means.
A total of 16 women ([means Ϯ SE] 21.8 Ϯ 1.7 years) and their infants (6.4 Ϯ 0.9 months; 9 males and 7 females) completed the study, and medical records were available for 9 of these pairs. Based on combined self-reports and medical records, the mean prepregnancy weight was 71.5 Ϯ 4.0 kg, and the mean pregnancy weight gain was 10.7 Ϯ 2.4 kg. Infants were full term with birth weights ranging from 2,495 to 4,309 g (3,381 Ϯ 121.0 g); WAZ scores averaged 0.47 Ϯ 0.23. Blood insulin concentrations averaged 11.5 Ϯ 1.6 mU/l. Gestational weight gain was significantly correlated to infant insulin concentrations (r ϭ 0.662; P ϭ 0.005); however, for nondiabetic women with verifiable pregnancy weight gain (n ϭ 8), this association was strengthened (r ϭ 0.763, P ϭ 0.028; Fig. 1 ). Infant insulin concentrations (n ϭ 16) were not associated with birth weight, infant age, WAZ scores, prepregnancy weight, or maternal age.
These data show that maternal weight gain predicted infant insulin concentrations, explaining nearly 60% of the variance in these values. Diabetes during pregnancy has been associated with cord blood insulin and with insulin concentrations in adolescence (1) , and in nondiabetic pregnancies, maternal weight gain was related to cord blood insulin in macrosomic neonates (2) . Currently, a weight gain of 6.8 -11.5 kg is recommended for overweight women, and obese women are advised to gain a minimum of 6.8 kg. In obese, nondiabetic women, minimal gestational weight gain (Ͻ5 kg) normalized obstetric outcomes, including hypertension, cesarean section, induction of labor, and macrosomia, and did not adversely affect fetal outcomes (3) . Utilizing an emerging obstetric outcome, infant insulin concentrations, our preliminary data support the contention that gestational weight gain should be carefully considered in overweight populations at high risk for diabetes. Differential analyses of our data show that minimal gestational weight gain in the nondiabetic women (Յ5 vs. Ͼ5 kg) was associated with lower infant insulin concentrations (7.2 Ϯ 0.6 vs. 13.4 Ϯ 2.0 mU/l; P ϭ 0.013). Together, the available data indicate that controlling weight gain during obese pregnancies may be advantageous and that more studies of this nature are warranted.
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